Skip to main content

Table 4 Treatment performed on the day of hospitalization

From: Intensive care unit versus high-dependency care unit admission on mortality in patients with septic shock: a retrospective cohort study using Japanese claims data

Ā 

Overall

ICU

HDU

nā€‰=ā€‰10,818

nā€‰=ā€‰6584 (60.9%)

nā€‰=ā€‰4234 (39.1%)

Vasoactive agents

Ā Dopamine, n (%)

2168 (20.0)

1413 (21.5%)

755 (17.8)

Ā Adrenaline, n (%)

982 (9.1)

720 (10.9%)

262 (6.2)

Ā Dobutamine, n (%)

868 (8.0)

649 (9.9%)

219 (5.2)

Ā Vasopressin, n (%)

1875 (17.3)

1479 (22.5%)

396 (9.4)

Ā ā‰„2 drugs, n (%)

4459 (41.2)

3146 (47.8%)

1313 (31.0)

Ā ā‰„3 drugs, n (%)

1193 (11.0)

924 (14.0%)

269 (6.4)

Transfusion

Ā Red blood cell, n (%)

1805 (16.7)

1404 (21.3)

401 (9.5)

Ā Platelet, n (%)

667 (6.2)

521 (7.9)

146 (3.5)

Ā Fresh frozen plasma, n (%)

1581 (14.6)

1300 (19.7)

281 (6.6)

Albumin, n (%)

3226 (29.8)

2403 (36.5)

823 (19.4)

Globulin, n (%)

1511 (14.0)

1105 (16.8)

406 (9.6)

Recombinant thrombomodulin, n (%)

2169 (20.1)

1281 (19.5)

888 (21.0)

Antithrombin III, n (%)

1108 (10.2)

827 (12.6)

281 (6.6)

Hydrocortisone, n (%)

2706 (25.0)

1922 (29.2)

784 (18.5)

Sedative drugs, n (%)

5796 (53.6)

4325 (65.7)

1471 (34.7)

Narcotic drugs, n (%)

4562 (42.2)

3481 (52.9)

1081 (25.5)

Prophylaxis of gastrointestinal ulcer, n (%)

6327 (58.5)

4470 (67.9)

1857 (43.9)

Prophylaxis of deep vein thrombosis, n (%)

3916 (36.2)

2762 (42.0)

1154 (27.3)

Rehabilitation, n (%)

516 (4.8)

469 (7.1)

47 (1.1)

Mechanical ventilation, n (%)

4049 (37.4)

2986 (45.4)

1063 (25.1)

CRRT, n (%)

1691 (15.6)

1351 (20.5)

340 (8.0)

PMX-DHP, n (%)

1025 (9.5)

746 (11.3)

279 (6.6)

VA-ECMO/IABP, n (%)

200 (1.9)

172 (2.6)

28 (0.7)

Central venous catheter, n (%)

7087 (65.5)

5028 (76.4)

2059 (48.6)

Arterial line, n (%)

6979 (64.5)

5159 (78.4)

1820 (43.0)

Urinary catheter, n (%)

8237 (76.1)

5109 (77.6)

3128 (73.9)

Nasogastric tube, n (%)

4449 (41.1)

3406 (51.7)

1043 (24.6)

Blood culture test, n (%)

9571 (88.5)

5799 (88.1)

3772 (89.1)

Antibiotics

Ā Penicillin, n (%)

3459 (32.0)

2087 (31.7)

1372 (32.4)

Ā Cephalosporin, n (%)

2566 (23.7)

1554 (23.6)

1012 (23.9)

Ā Carbapenem, n (%)

5896 (54.5)

3683 (55.9)

2213 (52.3)

Ā Quinolone, n (%)

500 (4.6)

361 (5.5)

139 (3.3)

Ā Anti-MRSA, n (%)

1484 (13.7)

1102 (16.7)

382 (9.0)

Ā Aminoglycoside, n (%)

208 (1.9)

119 (1.8)

89 (2.1)

Ā Metronidazole, n (%)

116 (1.1)

90 (1.4)

26 (0.6)

Ā Anti-fungal, n (%)

180 (1.7)

137 (2.1)

43 (1.0)

Ā Anti-viral, n (%)

248 (2.3)

176 (2.7)

72 (1.7)

Drainage

Ā Endoscopic, n (%)

357 (3.3)

178 (2.7)

179 (4.2)

Ā Percutaneous, n (%)

214 (2.0)

127 (1.9)

87 (2.1)

Ā Urinary, n (%)

754 (7.0)

388 (5.9)

366 (8.8)

Surgery

Ā Abdominal surgery, n (%)

1583 (14.6)

1207 (18.3)

376 (8.9)

Ā Limb surgery, n (%)

92 (0.9)

67 (1.0)

25 (0.6)

  1. CRRT continuous renal replacement therapy, PMX-DHP polymyxin B immobilized fiber column direct hemoperfusion, VA-ECMO venoatrial extracorporeal membrane oxygenation, IABP intra-aortic balloon pumping